# US 2022/0033909 A1 · Methods for simultaneous amplification of target loci

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0033909 A1
- Document ID: US20220033909A1
- Status: Published application
- Kind: A1
- Application number: 17/505,588
- Filed: 2021-10-19
- Published: 2022-02-03
- Earliest claimed: 2010-05-18
- Assignees: Natera, Inc.
- Applicants: Natera, Inc.
- Inventors: Joshua BABIARZ; Tudor Pompiliu CONSTANTIN; Lane A. EUBANK; George GEMELOS; Matthew Micah HILL; Huseyin Eser KIRKIZLAR; Matthew RABINOWITZ; Onur SAKARYA; Styrmir SIGURJONSSON; Bernhard ZIMMERMANN
- Web page: https://patentgrep.com/patent/US20220033909A1

## CPC

- C12Q 1/6883: for diseases caused by alterations of genetic material
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6809: Methods for determination or identification of nucleic acids involving differential detection
- C12Q 1/6811: Selection methods for production or design of target specific oligonucleotides or binding molecules
- C12Q 1/6844: Nucleic acid amplification reactions
- C12Q 1/6848: characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
- C12Q 1/6851: Quantitative amplification
- C12Q 1/6855: Ligating adaptors
- C12Q 1/6858: Allele-specific amplification
- C12Q 1/6869: Methods for sequencing
- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- G16B 20/10: Ploidy or copy number detection
- G16B 20/20: Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
- C12Q 2600/156: Polymorphic or mutational markers
- G16B 20/00: ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B 40/00: ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY

## Abstract

The invention provides methods for simultaneously amplifying multiple nucleic acid regions of interest in one reaction volume as well as methods for selecting a library of primers for use in such amplification methods. The invention also provides library of primers with desirable characteristics, such as minimal formation of amplified primer dimers or other non-target amplicons.

## Claims

### Claim 1

A method for preparing a preparation of amplified DNA derived from one or more fetal or embryonic cells of an unborn fetus or embryo useful for reconstructing at least a portion of the genome of the fetus or embryo, comprising:
(a) extracting genomic DNA from the one or more fetal or embryonic cells;
(b) preparing a preparation of amplified DNA by amplification of at least 1,000 polymorphic loci from the genomic DNA extracted in (a) to obtain amplified DNA;
(c) analyzing the amplified DNA obtained in (b) by high-throughput sequencing to obtain genetic data of the fetus or embryo at the polymorphic loci, and reconstructing at least a portion of the genome of the fetus or embryo using the genetic data of the fetus or embryo and haplotypes of at least one biological parent of the fetus or embryo at the polymorphic loci.

### Claim 2 (depends on 1)

The method of claim 1, wherein the polymorphic loci are SNP loci.

### Claim 3 (depends on 1)

The method of claim 1, wherein step (a) comprises extracting genomic DNA from one or more fetal cells.

### Claim 4 (depends on 1)

The method of claim 1, wherein step (a) comprises extracting genomic DNA from one or more embryonic cells.

### Claim 5 (depends on 1)

The method of claim 1, wherein step (a) comprises extracting genomic DNA from a single fetal or embryonic cell.

### Claim 6 (depends on 1)

The method of claim 1, wherein step (b) comprises ligation of adaptors to the genomic DNA to obtain adaptor-ligated DNA and performing universal amplification on the adaptor-ligated DNA.

### Claim 7 (depends on 1)

The method of claim 1, wherein step (b) comprises performing targeted multiplex amplification of the at least 1,000 polymorphic loci using at least 1,000 different target-specific primers.

### Claim 8 (depends on 1)

The method of claim 1, wherein step (b) comprises barcoding PCR.

### Claim 9 (depends on 1)

The method of claim 1, wherein step (c) comprises reconstructing at least a portion of the genome of the fetus or embryo using the genetic data of the fetus or embryo and haplotypes of both biological parents of the fetus or embryo at the polymorphic loci.

### Claim 10 (depends on 1)

The method of claim 1, wherein the method further comprises measuring genetic data of at least one biological parent of the fetus or embryo, and phasing the genetic data to obtain haplotypes of the biological parent at the polymorphic loci.

### Claim 11 (depends on 1)

The method of claim 1, wherein the method further comprises measuring genetic data of both biological parents of the fetus or embryo, and phasing the genetic data to obtain haplotypes of both biological parents at the polymorphic loci.

### Claim 12 (depends on 1)

The method of claim 1, wherein a haplotype is determined for one or more chromosomes of the fetus or embryo.

### Claim 13 (depends on 1)

The method of claim 1, wherein a haplotype is determined for at least 30% of the genome of the fetus or embryo.

### Claim 14 (depends on 13)

The method of claim 13, wherein the haplotype determination of the fetus or embryo comprises identifying which allele is present for the at least 1,000 polymorphic loci.

### Claim 15

A method for preparing a preparation of amplified DNA derived from one or more fetal or embryonic cells of an unborn fetus or embryo useful for reconstructing at least a portion of the genome of the fetus or embryo, comprising:
(a) extracting genomic DNA from the one or more fetal or embryonic cells;
(b) preparing a preparation of amplified DNA by targeted multiplex amplification of 1,000 to 100,000 SNP loci from the genomic DNA extracted in (a) to obtain amplified DNA;
(c) analyzing the amplified DNA obtained in (b) by high-throughput sequencing to obtain genetic data of the fetus or embryo at the SNP loci, and reconstructing at least a portion of the genome of the fetus or embryo using the genetic data of the fetus or embryo and haplotypes of both biological parents of the fetus or embryo at the SNP loci.
